Laurus Labs Limited

LAURUSLABS.NS·NSE·Healthcare
Compare
2,346.00+22.20 (+0.96%)today
At close: Nov 5, 3:28 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,323.80
Open2,328.30
Day range2,288.202,346.00
52-week range917.952,441.90
Off day high0.00%
Off 52-week high−3.93%
Volume1.45M
Avg. volume (3M)2.46M
Market cap1.27T
EPS (TTM)24.78
Forward P/E66.24
P/E ratio (TTM)94.67
Dividend yield0.09% (2.00)
Beta (5Y)0.22
Shares outstanding540.31M
Short interest—
Earnings dateOct 29, 2026 (est.)
Analyst target2,156.29
Profit margin17.13%

Against its peers

Compare in full ›
LAURUSLABS.NS AUROPHARMA.BO LUPIN.NS DRREDDY.BO ALKEM.NS IPCALAB.NS
Market cap 1.27T 1.04T 909.09B 1.13T 620.54B 494.62B
P/E (TTM) 94.7 30.4 17.5 20.1 28.8 37.8
Forward P/E 66.2 23.9 19.6 24.8 23.2 27.7
Price/book 20.9 3.0 3.8 3.0 4.5 6.1
Dividend yield 0.09% 0.33% 0.90% 0.65% 0.38% 0.30%
1-year change +137.17% +1.70% +2.72% +0.33% −7.57% +51.13%
Today +0.96% +5.13% −1.03% −0.82% −0.51% −1.14%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company Mkt cap Price Today
Daewoong Pharmaceutical Co., Ltd069620.KS · Seoul, South Korea 1.23T 106,700.00 +3.69%
Zydus Lifesciences LimitedZYDUSLIFE.BO · Ahmedabad, India 1.19T 1,196.40 +0.54%
PT Pyridam Farma TbkPYFA.JK · Jakarta Selatan, Indonesia 1.21T 108.00 −4.42%
Dr. Reddy's Laboratories LimitedDRREDDY.BO · Hyderabad, India 1.13T 1,360.80 −0.82%
Kyowa Kirin Co., Ltd.4151.T · Chiyoda, Japan 1.37T 2,620.50 +6.07%
Cipla LimitedCIPLA.BO · Mumbai, India 1.13T 1,401.75 +0.12%
Eisai Co., Ltd.4523.T · Tokyo, Japan 1.49T 5,280.00 +6.09%
PT Merck TbkMERK.JK · Jakarta Timur, Indonesia 1.58T 3,530.00 +2.92%

The stocks whose daily moves over the past year went most closely with Laurus Labs's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Zydus Lifesciences LimitedZYDUSLIFE.BO · Correlation 0.50 1.19T 1,196.40 +0.54%
Divi's Laboratories LimitedDIVISLAB.BO · Correlation 0.46 2.69T 10,150.00 +1.14%
Divi's Laboratories LimitedDIVISLAB.NS · Correlation 0.44 2.69T 10,140.50 +1.03%
Mankind Pharma LimitedMANKIND.NS · Correlation 0.42 1.04T 2,518.00 −0.78%
Granules India LimitedGRANULES.NS · Correlation 0.40 216.71B 794.45 −0.02%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP.NS · Correlation 0.39 1.20T 8,371.00 −2.66%
Sai Life Sciences LimitedSAILIFE.NS · Correlation 0.38 338.79B 1,594.50 +3.13%
Neuland Laboratories LimitedNEULANDLAB.NS · Correlation 0.37 253.81B 19,783.00 +1.06%

What visitors to Laurus Labs's page also look at.

Company Mkt cap Price Today
DEEPAK NITRITE LTDDEEPAKNTR.NS 210.59B 1,544.00 −2.18%
SYNGENE INTERNATIONAL LTDSYNGENE.NS 166.43B 414.10 −0.81%
DIVI S LABORATORIES LTDDIVISLAB.NS 2.69T 10,140.50 +1.03%
GRANULES INDIA LIMITEDGRANULES.NS 216.71B 794.45 −0.02%
DIXON TECHNO (INDIA) LTDDIXON.NS 771.73B 12,616.00 +2.65%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All LAURUSLABS.NS news ›
InvestyWise·Positive

Laurus Labs reports 29% revenue growth in Q2 FY27

Laurus Labs announced strong Q2 FY27 results with total revenues of INR2,206 crores, a 29% YoY increase. CDMO and affordable medicines segments drove growth, with healthy margins and strategic investments in peptides and oligonucleotides.…

PRLB
TradingView·Positive

Laurus Labs Ltd.

LAURUSLABS Stock Price and Chart — NSE:LAURUSLABS TradingView Compare with Laurus Labs Ltd. Q2 FY26 saw 35% revenue growth, margin expansion, and robust ARV and CDMO performance. Major CapEx and new Vizag facility support long-term growth,…

TSLA
BusinessLine·Positive

Laurus Labs’ Q2 Results: Net more than doubles at ₹441 cr

Laurus Labs’ net profit more than doubled at ₹441 crore in the second quarter of the current financial year ended September compared to ₹195 crore in the corresponding quarter of the previous financial year. The total revenue of the…

The Hindu·Positive

Laurus Labs Q2 net profit surges on 33% rise in revenue

Updated - October 29, 2026 08:56 pm IST - HYDERABAD Pharmaceutical and biotechnology company Laurus Labs reported a more than twofold increase in consolidated net profit to ₹436.74 crore for the September quarter, driven by a 33% growth in…

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance